27/02/2025
18:30 - 19:30
CPD Points For Attending This Event: 1
Webinar
This event has already taken place.
Age-related macular degeneration (AMD) advances through early, intermediate, and late stages. While anti-VEGF therapies are effective for wet AMD, there are no approved treatments currently available for dry AMD in the UK. Emerging approaches, including sustained-release anti-VEGF, gene therapy, and complement inhibitors, offer hope for dry AMD.
Dr. Yasmine Abdallah, M.S, FRCOphth.,
Consultant Ophthalmologist, Uveitis Service Lead, University Hospitals of Derby and Burton NHS Trust.
The webinar was presented by Dr. Yasmine Abdalla, Consultant Ophthalmologist. Dr. Abdalla is the Uveitis Service Lead at the University Hospitals of Derby and Burton NHS Foundation Trust, and is a fellow of the Royal College of Ophthalmologists.
The webinar is accredited for 1 CPD point for Optometrists and Ophthalmologists.
24/04/2025 - 18:30 - 19:30
